Daiwa Securities Group
IMVT icon

Daiwa Securities Group’s Immunovant IMVT Stock Holding History

Daiwa Securities Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-501
Closed -$13K – 1302
2025
Q4 		$13K Sell
501
-80
-14% -$1.78K ﹤0.01% 1173
2025
Q3 		$9K Hold
581
– – ﹤0.01% 1162
2025
Q2 		$9K Hold
581
– – ﹤0.01% 1123
2025
Q1 		$10K Buy
581
+97
+20% +$2.03K ﹤0.01% 1096
2024
Q4 		$12K Sell
484
-53
-10% -$1.5K ﹤0.01% 1109
2024
Q3 		$15K Hold
537
– – ﹤0.01% 1114
2024
Q2 		$14K Hold
537
– – ﹤0.01% 1149
2024
Q1 		$17K Sell
537
-55
-9% -$2.01K ﹤0.01% 1143
2023
Q4 		$25K Buy
592
+72
+14% +$2.65K ﹤0.01% 1114
2023
Q3 		$20K Hold
520
– – ﹤0.01% 1097
2023
Q2 		$10K Hold
520
– – ﹤0.01% 1138
2023
Q1 		$8K Hold
520
– – ﹤0.01% 1122
2022
Q4 		$9K Buy
520
+126
+32% +$1.59K ﹤0.01% 1118
2022
Q3 		$2K Hold
394
– – ﹤0.01% 1231
2022
Q2 		$2K Hold
394
– – ﹤0.01% 1242
2022
Q1 		$2K Hold
394
– – ﹤0.01% 1254
2021
Q4 		$3K Hold
394
– – ﹤0.01% 1244
2021
Q3 		$3K Buy
394
+210
+114% +$1.89K ﹤0.01% 1213
2021
Q2 		$2K Hold
184
– – ﹤0.01% 1140
2021
Q1 		$3K Hold
184
– – ﹤0.01% 1107
2020
Q4 		$8K Buy
+184
New +$8.51K ﹤0.01% 1028

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Daiwa Securities Group's IMVT Position: Q1 2026 in Review

Daiwa Securities Group sold out of Immunovant (IMVT) in Q1 2026, closing a stake of 501 shares — an estimated $13K sold.

Daiwa Securities Group first reported a position in IMVT in Q4 2020 and held it in 21 quarters. The position peaked at $25K in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Daiwa Securities Group reported no remaining Immunovant position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 501 Immunovant shares in Q1 2026, an estimated $13K.
  • Daiwa Securities Group first reported a position in Immunovant in Q4 2020 and held it in 21 quarters.
  • Daiwa Securities Group's Immunovant position peaked at $25K in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.